Reuters - Roche Holding AG and Genentech Inc said on Monday a study into the benefits of combining their Tarceva and Avastin drugs for lung cancer patients did not show an increase in overall survival.
Independent honest reviews of most effective natural herbal supplements
Reuters - Roche Holding AG and Genentech Inc said on Monday a study into the benefits of combining their Tarceva and Avastin drugs for lung cancer patients did not show an increase in overall survival.
The URI to TrackBack this entry is: http://herbal-review.com/2008/10/06/two-drugs-dont-boost-lung-cancer-survival-roche-reuters/trackback/
Please healthy :)
You must be logged in to post a comment.
|No results yet!
25 queries. 0.699 seconds